IDEAYA Biosciences, Inc. (IDYA)
37.55
+1.12
(+3.07%)
USD |
NASDAQ |
Jan 09, 13:11
IDEAYA Biosciences Research and Development Expense (Annual): 294.67M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Sarepta Therapeutics, Inc. | 778.47M |
| Rezolute, Inc. | 61.53M |
| GT Biopharma, Inc. | 5.798M |